13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details


Clinical trials : 3,342 Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2006-006465-16-DE
(EUCTR)
03/05/2007Pilot trial of recombinant human growth hormone for remyelination in multiple sclerosis - rhGH in MSPilot trial of recombinant human growth hormone for remyelination in multiple sclerosis - rhGH in MS Multiple Sclerosis
MedDRA version: 9.1;Level: LLT;Classification code 10063399;Term: Relapsing-remitting multiple sclerosis
MedDRA version: 9.1;Classification code 10063400;Term: Secondary progressive multiple sclerosis
Trade Name: Genotropin
Product Name: Genotropin
INN or Proposed INN: human recombinant growth hormone
University of LeipzigNULLNot RecruitingFemale: yes
Male: yes
Phase 2Germany